Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis
- PMID: 15606614
- PMCID: PMC1809276
- DOI: 10.1111/j.1365-2249.2005.02677.x
Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis
Abstract
Diabetes mellitus is an important predisposing factor for tuberculosis. The aim of this study was to investigate the mechanism underlying this association using a murine model. Mice with streptozotocin-induced diabetes mellitus were prone to Mycobacterium tuberculosis infection, as indicated by increased numbers of live bacteria in lung, liver and spleen. In diabetic mice, the levels of IL-12 and IFN-gamma in the lung, liver and spleen were lower than those in control animals on day 14 postinfection, while the opposite was true for IL-4 levels in the lung and liver. The expression pattern of inducible nitric oxide synthase (iNOS), in the two mice types was as for IL-12 and IFN-gamma. In addition, peritoneal exudate cells obtained from diabetic mice produced lower amounts of IL-12 and NO than those from control mice, when stimulated in vitro with M. bovis BCG. Spleen cells from diabetic mice infected with M. tuberculosis produced a significantly lower amount of IFN-gamma upon restimulation with purified protein derivatives (PPD) than those from infected nondiabetic mice. Interestingly, addition of high glucose levels (33 mM) to the cultures of PPD-restimulated spleen cells reduced the synthesis of IFN-gamma only in diabetic mice, and not in nondiabetic mice. Finally, control of blood glucose levels by insulin therapy resulted in improvement of the impaired host protection and Th1-related cytokine synthesis. Our results suggest that the reduced production of Th1-related cytokines and NO account for the hampered host defense against M. tuberculosis infection under diabetic conditions.
Figures




Similar articles
-
[TH1 response in the experimental infection with Trypanosoma cruzi].Medicina (B Aires). 1999;59 Suppl 2:84-90. Medicina (B Aires). 1999. PMID: 10668248 Spanish.
-
[Tuberculosis in compromised hosts].Kekkaku. 2003 Nov;78(11):717-22. Kekkaku. 2003. PMID: 14672050 Japanese.
-
Interleukin-12p40 overexpression promotes interleukin-12p70 and interleukin-23 formation but does not affect bacille Calmette-Guérin and Mycobacterium tuberculosis clearance.Immunology. 2007 Nov;122(3):350-61. doi: 10.1111/j.1365-2567.2007.02646.x. Epub 2007 Jul 9. Immunology. 2007. PMID: 17623032 Free PMC article.
-
[Up-to-date understanding of tuberculosis immunity].Kekkaku. 2003 Jan;78(1):51-5. Kekkaku. 2003. PMID: 12683337 Review. Japanese.
-
Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens.Immunol Lett. 1994 Dec;43(1-2):87-94. doi: 10.1016/0165-2478(94)00158-8. Immunol Lett. 1994. PMID: 7537721 Review.
Cited by
-
Intravenous Mycobacterium Bovis Bacillus Calmette-Guérin Ameliorates Nonalcoholic Fatty Liver Disease in Obese, Diabetic ob/ob Mice.PLoS One. 2015 Jun 3;10(6):e0128676. doi: 10.1371/journal.pone.0128676. eCollection 2015. PLoS One. 2015. PMID: 26039731 Free PMC article.
-
Active screening of patients with diabetes mellitus for pulmonary tuberculosis in a tertiary care hospital in Sri Lanka.PLoS One. 2021 Apr 8;16(4):e0249787. doi: 10.1371/journal.pone.0249787. eCollection 2021. PLoS One. 2021. PMID: 33831095 Free PMC article.
-
Glycemic Control and the Risk of Tuberculosis: A Cohort Study.PLoS Med. 2016 Aug 9;13(8):e1002072. doi: 10.1371/journal.pmed.1002072. eCollection 2016 Aug. PLoS Med. 2016. PMID: 27505150 Free PMC article.
-
Advancing personalized medicine for tuberculosis through the application of immune profiling.Front Cell Infect Microbiol. 2023 Feb 10;13:1108155. doi: 10.3389/fcimb.2023.1108155. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 36844400 Free PMC article. Review.
-
Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis.PLoS One. 2010 Feb 4;5(2):e9051. doi: 10.1371/journal.pone.0009051. PLoS One. 2010. PMID: 20140219 Free PMC article.
References
-
- Kim SJ, Hong YP, Lew WJ, Yang SC, Lee EG. Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis. 1995;76:529–33. - PubMed
-
- Yamagishi F. Medical risk factors of tuberculosis and countermeasures. Kekkaku. 2002;77:799–804. (in Japanese) - PubMed
-
- Delamaire M, Maugendre D, Moreno M, Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med. 1997;14:29–34. - PubMed
-
- Naghibi M, Smith RP, Baltch AL, Gates SA, Wu DH, Hammer MC, Michelsen PB. The effect of diabetes mellitus on chemotactic and bactericidal activity of human polymorphonuclear leukocytes. Diabetes Res Clin Pract. 1987;4:27–35. - PubMed
-
- Wilson RM, Tomlinson DR, Reeves WG. Neutrophil sorbitol production impairs oxidative killing in diabetes. Diabet Med. 1987;4:37–40. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical